The 4thannual Cancer Vaccines conference will strengthen knowledge of targeted immunotherapies taking the foreground in revolutionizing cancer vaccines as well as look at the practicalities towards achieving sustained immune response.Featured Speakers Include:Professor Farzin Farzaneh, Professor of Molecular Medicine, Kings College LondonMichael Hanna, Chairman and CEO, VaccinogenDerek O’Hagan, Global Head of Vaccine Chemistry and Formulation, GSKSebastian Kreiter, VP Immunotherapy, BioNTech RNA PharmaceuticalsVaios Karanikas, Biomarker & Experimental Medicine Leader, Tumor Immunology, RocheThomas Felzmann, CEO, Activartis Biotech GmbHPeter L. Andersen, VP Vaccine R&D, Statens Serum InstitutRavi A. Madan, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer InstituteProfessor Dr. Dirk Jager, Medical Oncology, National Center for Tumor Diseases, University Hospital HeidelbergContact the team on +44 (0)870 9090 712